amyloid-beta

Documents about amyloid-beta

• CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study#202760IRIS
• Deep Brain Stimulation in Alzheimer's Disease: Biomarkers and Dose Optimization#889153ClinicalTrials.gov
• Dexmedetomidine Exerts Multi-Level Effects to Ameliorate Alzheimer’s Disease Pathology in the Adult Zebrafish Brain#256625İzmir Yüksek Teknoloji Enstitüsü
• SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid#886116ClinicalTrials.gov
• Computational design of new peptide inhibitors for amyloid beta (A beta) aggregation in Alzheimer's disease: application of a novel methodology#954604Koc University Digital Collections
• Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation#268316Europe PMC
• Age-related increase in plasma p-tau217 in amyloid-beta-negative cognitively unimpaired individuals affects diagnostic interpretation#273351Europe PMC
• Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease#935962Repositorio de Universidad Autónoma de Chile.
• Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease#948260Repositorio de Universidad Autónoma de Chile.
• The Multiple Functions of Amyloid Beta in the Gut Epithelium and the Role of the Microbiota: A Study in the APP/PS1 Animal Model Subjected to Chronic Synbiotic Treatment.#317615NCBI PubMed Central
• Higher Frontal Cortex Angiotensin Type 2 Receptor-Interacting Protein (ATIP) Levels Are Associated With a Lower Amyloid-Beta Burden in Postmortem Brains of Older Adults With Alzheimer's Disease.#625840NCBI PubMed Central
• Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease#947726Repositorio de Universidad Autónoma de Chile.
• Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease using Blood-Based Biomarkers and Amyloid-Beta PET: A Survival Analysis Approach#235048Harvard DASH
• Proteinopathies Expression in Skin of Neurodegenerative Disorders#835436ClinicalTrials.gov
• Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm#947744Repositorio de Universidad Autónoma de Chile.
• A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants#827500ClinicalTrials.gov
• Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme#954569Koc University Digital Collections
• An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease#868727ClinicalTrials.gov
• When does Alzheimer's disease start? Plasma Aβ42/40 assays show steep changes at Aβ-PET Centiloid 15, mean age of 66 years#654726Research Online
• A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population#890836ClinicalTrials.gov
• FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD#898586ClinicalTrials.gov